pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Tag › aflibercept switching

    Results of a 12-month follow-up of neovascular age-related macular degeneration after switching an angiogenesis inhibitor in real clinical practice

    Редактор | 2018, Practical medicine 03 (18) Ophthalmology | 10 апреля, 2018

    E.V. BOBYKIN, S.A. KOROTKIKH, R.V. BUSLAEV Ural State Medical University, 3 Repin St., Ekaterinburg, Russian Federation, 620028   Bobykin E.V. ― Cand. Med. Sc., Assistant Professor, Assistant Professor of the Ophthalmology Department, tel. (343) 214-80-00, e-mail: oculist.ev@gmail.com Korotkikh S.A. ― D. Med. Sc., Professor, Head of the Ophthalmology Department, tel. (343) 214-86-67, e-mail: med@usma.ru Buslaev R.V. […]

    Tag: 2018, aflibercept switching, E.V. BOBYKIN, neovascular («wet») age-related macular degeneration, Practical medicine 03 (18) Ophthalmology, R.V. BUSLAEV, ranibizumab, S.A. KOROTKIKH, switch back
    Комментарии к записи Results of a 12-month follow-up of neovascular age-related macular degeneration after switching an angiogenesis inhibitor in real clinical practice отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©